Bruck syndrome 1
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
|
22949511 |
2013 |
Bruck syndrome 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
|
22949511 |
2013 |
Bruck syndrome 1
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient.
|
22085994 |
2012 |
Bruck syndrome 1
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in PLOD2 cause autosomal-recessive connective tissue disorders within the Bruck syndrome--osteogenesis imperfecta phenotypic spectrum.
|
22689593 |
2012 |
Bruck syndrome 1
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
|
20839288 |
2011 |
Bruck syndrome 1
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
FKBP10 and Bruck syndrome: phenotypic heterogeneity or call for reclassification?
|
20696291 |
2010 |
Bruck syndrome 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Bruck syndrome 1
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
OSTEOGENESIS IMPERFECTA, TYPE XI
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
Our study identified, for the first time, a private pathogenic splice site mutation in FKBP10 gene and further prove the involvement of this gene in the rare cases of autosomal recessive OI type XI with distinguished clinical manifestations.
|
29801479 |
2018 |
OSTEOGENESIS IMPERFECTA, TYPE XI
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, we report for the first time that these novel pathogenic mutations of FKBP10 can lead to the extremely rare type XI OI without contractures, which expands the genotypic spectrum of OI.
|
27762305 |
2017 |
OSTEOGENESIS IMPERFECTA, TYPE XI
|
0.630 |
CausalMutation
|
disease |
CLINVAR |
Novel FKBP10 Mutation in a Patient with Osteogenesis Imperfecta Type XI.
|
27362741 |
2016 |
OSTEOGENESIS IMPERFECTA, TYPE XI
|
0.630 |
GeneticVariation
|
disease |
BEFREE |
In another branch, a child with moderate type XI OI has a homozygous FKBP10 mutation (c.1271_1272delCCinsA).
|
22718341 |
2012 |
OSTEOGENESIS IMPERFECTA, TYPE XI
|
0.630 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
OSTEOGENESIS IMPERFECTA, TYPE XI
|
0.630 |
Biomarker
|
disease |
CTD_human |
|
|
|
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in FKBP10 and PLOD2 were identified as the underlying genetic defects of Bruck syndrome.
|
29177700 |
2018 |
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Grouping according to phenotypic and radiographic features revealed four individuals with Bruck syndrome due to FKBP10 mutations, three patients with hypertrophic callus caused by IFITM5 mutations, and twenty with pronounced bone bowing, of which eight carried WNT1 mutations.
|
29499418 |
2018 |
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In family 3, the proband displayed a novel compound heterozygous mutation in FKBP10, c.813_814delGA (p.Glu271AspfsX101) and c.831delC (p.Gly278AlafsX20), and did not have Bruck syndrome.
|
29512769 |
2018 |
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Bruck Syndrome is a connective tissue disease associated with inactivating mutations in lysyl hydroxylase 2 (LH2/PLOD2) or FK506 binding protein 65 (FKBP65/FKBP10).
|
28378777 |
2017 |
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the FK506 Binding Protein 10 (FKBP10), gene encoding the 65-kDa protein FKBP65, cause a recessive form of OI and Bruck syndrome, the latter being characterized by joint contractures in addition to low bone mass.
|
28206698 |
2017 |
Bruck syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Recently, several studies described FKBP10 mutations in OI-like and BS patients, suggesting that FKBP10 is a bonafide BS locus.
|
27146342 |
2016 |
Bruck syndrome
|
0.400 |
Biomarker
|
disease |
BEFREE |
Moreover, FKBP65 does not interact with LH1 and LH3, explaining why in BS triple-helical hydroxylysines are not affected.
|
27298363 |
2016 |
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recently, mutations in FKBP10, localised to chromosome 17q21, have been identified in some patients of Bruck syndrome.
|
25931047 |
2015 |
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Recessive mutations in FKBP10 at 17q21.2, encoding FKBP65, cause both osteogenesis imperfecta (OI) and Bruck syndrome (OI plus congenital contractures).
|
23712425 |
2013 |
Bruck syndrome
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
With the exception of a FKBP10 mutation in the BS case, all changes are novel.
|
23613367 |
2013 |
Bruck syndrome
|
0.400 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
|
22949511 |
2013 |